Cargando…

Switching to the Dry-Powder Inhaler Easyhaler(®): A Narrative Review of the Evidence

Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a substantial contributing factor to the suboptimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavorini, Federico, Chudek, Jerzy, Gálffy, Gabriella, Pallarés-Sanmartin, Abel, Pelkonen, Anna S., Rytilä, Paula, Syk, Jörgen, Szilasi, Maria, Tamási, Lilla, Xanthopoulos, Athanasios, Haahtela, Tari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477976/
https://www.ncbi.nlm.nih.gov/pubmed/34581994
http://dx.doi.org/10.1007/s41030-021-00174-5
Descripción
Sumario:Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a substantial contributing factor to the suboptimal clinical control of both conditions. The practicality, dependability, and acceptability of different inhalers influence the overall effectiveness and success of inhalation therapy. In this paper, experts from various European countries (Finland, Germany, Hungary, Italy, Poland, Spain, and Sweden) address inhaler selection with special focus on the Easyhaler(®) device, a high- or medium–high resistance dry-powder inhaler (DPI). The evidence examined indicates that use of the Easyhaler is associated with effective control of asthma or COPD, as shown by the generally accepted indicators of treatment success. Moreover, the Easyhaler is widely accepted by patients, is reported to be easy to learn and teach, and is associated with patient adherence. These advantages help patient education regarding correct inhaler use and the rational selection of drugs and devices. We conclude that switching inhaler device to the Easyhaler may improve asthma and COPD control without causing any additional risks. In an era of climate change, switching from pressurized metered-dose inhalers to DPIs is also a cost-effective way to reduce emissions of greenhouse gases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41030-021-00174-5.